• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070300-48
Device Problems Difficult to Remove (1528); Material Separation (1562); Difficult to Advance (2920); Failure to Deflate (4060)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/20/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that the procedure was to treat the mid left anterior descending (lad) coronary artery with heavy calcification.Several pre-dilatations were performed and the 3.0x48 mm xience xpedition stent delivery system (sds) was advanced to the lesion and resistance was noted with a non-abbott guide catheter extension.The delivery system was inflated once to 10 atmospheres, and the stent was deployed.Deflation was attempted but there was no pressure reduction.Negative pressure was applied several times for 10-20 seconds.Several bail out techniques were attempted but were not successful and there was resistance still during removal and the balloon would not move.During this process, the hypotube separated and was taken out of the patient but the balloon was still inflated.A snare was attempted but was unsuccessful.The patient was then sent to surgery for coronary artery bypass surgery to cut the left main to the lad and the balloon was removed.The patient was hospitalized additional time.The stent remains implanted.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported shaft separation was confirmed.The reported difficulty to advance and difficulty to remove could not be replicated in a testing environment as they are related to operational context of the procedure.The reported failure to deflate could not be confirmed due to the condition the device was received for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulty to advance (guiding catheter and anatomy), difficulty to remove, shaft separation and treatment appear to be related to circumstances of the procedure.The investigation was unable to determine a conclusive cause for the reported deflation issues.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18113557
MDR Text Key327878498
Report Number2024168-2023-12517
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeSZ
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1070300-48
Device Lot Number3032241
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/15/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASAHI SION BLUE 0.014
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Weight47 KG
-
-